30 July 2021
e-therapeutics plc
Total Voting Rights
e-therapeutics plc (AIM: ETX.L, "e-therapeutics'" or "the Company") , announces that in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company has 514,553,598 ordinary shares of 0.1 pence each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 514,553,598 .
The above figure of 514,553,598 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.
Enquiries:
e-therapeutics plc |
|
Ali Mortazavi, CEO Karl Keegan, CFO
|
Tel: +44 (0)1993 883 125 www.etherapeutics.co.uk |
|
|
SP Angel Corporate Finance LLP |
Tel: +44(0)20 3470 0470 |
Nominated Adviser and Broker |
|
Matthew Johnson/Caroline Rowe (Corporate Finance) |
|
Vadim Alexandre/Rob Rees (Corporate Broking) |
|